Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections.

Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections. Med Mal Infect. 2019 Oct 14;: Authors: Bru JP, Alfandari S, Bleibtreu A, Chavanet P, Gauzit R, Lescure X, Lesprit P, Tattevin P PMID: 31623961 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31623961?dopt=Abstract

Source: Medecine et Maladies Infectieuses - October 19, 2019 Category: Infectious Diseases Tags: Med Mal Infect Source Type: research

More News: Infectious Diseases